Are anti-inflammatory properties of lipoic acid associated with The formation of hydrogen sulfide?

Pharmacological Reports

Volumn 65, Issue 4, 2013, Pages 1018-1024

  Dudek, Magdalena ^a   Bilska Wilkosz, Anna ^a   Knutelska, Joanna ^a   Mogilski, Szczepan ^a   Bednarski, Marek ^a   Zygmunt, Malgorzata ^a   Iciek, Malgorzata ^a   Sapa, Jacek ^a   Bugajski, Dominik ^a   Filipek, Barbara ^a   Wlodek, Lidia ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Anti inflammatory properties; Carrageenan induced paw edema; Dihydrolipoic acid; Glibenclamide; Hydrogen sulfide; Lipoic acid

Indexed keywords

CARRAGEENAN; GLIBENCLAMIDE; HYDROGEN SULFIDE; INDOMETACIN; POLYSORBATE 80; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; ENZYME RELEASE; IN VIVO STUDY; INFLAMMATION; MALE; MATHEMATICAL COMPUTING; MONOTHERAPY; MOUSE; NONHUMAN; PAW EDEMA; PLETHYSMOGRAPHY; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; GLYBURIDE; HINDLIMB; HYDROGEN SULFIDE; INDOMETHACIN; MALE; MICE; POTASSIUM CHANNEL BLOCKERS; THIOCTIC ACID;

EID: 84886461862     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71084-3     Document Type: Article

References (55)

1. Bast A, Haenen GR: Lipoic acid: a multifunctional antioxidant. Biofactors, 2003, 17, 207-213.
2. Bhatia M, Sidhapuriwala J, Moochhala SM, Moore PK: Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in The rat. Br J Pharmacol, 2005, 145, 141-144.
3. Biewenga GP, Haenen GR, Bast A: The pharmacology of The antioxidant lipoic acid. Gen Pharmacol, 1997, 29, 315-331
4. Biewenga G, Haenen GR, Bast A: The role of lipoic acid in The treatment of diabetic polyneuropathy. Drug Metab Rev, 1997, 29, 1025-1054.
5. Bilska A, Dudek M, Iciek M, Kwiecieñ I, Sokolowska-Jeewicz M, Filipek, B, Wlodek L: The biological actions of lipoic acid associated with sulfane sulfur metabolism. Pharmacol Rep, 2008, 60, 225-232.
6. Bilska A, Wlodek L: Lipoic acid -The drug of The future? Pharmacol Rep, 2005, 57, 570-577.
7. Bitar MS, Ayed AK, Abdel-Halim SM, Isenovic ER, Al-Mulla F: Inflammation and apoptosis in aortic tissues of aged type II diabetes: amelioration with a-lipoic acid through phosphatidylinositol 3-kinase/Akt-dependent mechanism. Life Sci, 2010, 86, 844-853.
8. Borcea V, Nourooz-Zadeh J, Wolff SP, Klevesath M, Hofmann M, Urich H, Wahl P: a-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic Biol Med, 1999, 26, 1495-1500.
9. Busija DW, Lacza Z, Rajapakse N, Shimizu K, Kis B, Bari F, Domoki F, Horiguchi T: Targeting mitochondrial ATP-sensitive potassium channels -A novel approach to neuroprotection. Brain Res Brain Res Rev, 2004, 46, 282-294.
10. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH: a-Lipoic acid in liver metabolism and disease. Free Radic Biol Med, 1998, 24, 1023-1039.
11. Butler JA, Hagen TM, Moreau R: Lipoic acid improves hypertriglyceridemia by stimulating triacylglycerol clearance and downregulating liver triacylglycerol secretion. Arch Biochem Biophys, 2009, 485, 63-71.
12. Cho YS, Lee J, Lee TH, Lee EY, Lee KU, Park JY, Moon HB: a-Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Allergy Clin Immunol, 2004, 114, 429-435.
13. Cremer DR, Rabeler R, Roberts A, Lynch B: Long-term safety of a-lipoic acid (ALA) consumption: A 2-year study. Regul Toxicol Pharmacol, 2006, 46, 193-201.
14. Cremer DR, Rabeler R, Roberts A, Lynch B: Safety evaluation of a-lipoic acid (ALA). Regul Toxicol Pharmacol, 2006, 46, 29-41.
15. Deplancke B, Gaskins HR: Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epiThelial cells. FASEB J, 2003, 17, 1310-1312.
16. Di Rosa M, Sorrentiono L: The mechanism of The inflammatory effect of carrageenan. Eur J Pharmacol, 1968, 4, 340-342.
17. El-Shitany NA, El-Masry SA, El-Ghareib MA, El-Desoky K: Thioctic acid protects against carrageenaninduced acute inflammation in rats by reduction in oxidative stress, downregulation of COX-2 mRNA and enhancement of IL-10 mRNA. Fundam Clin Pharmacol, 2010, 24, 91-99.
18. Fiorucci S, Distrutti E, Cirino G, Wallace JL: The emerging roles of hydrogen sulfide in The gastrointestinal tract and liver. Gastroenterology, 2006, 131, 259-271.
19. Goraca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B: Lipoic acid -biological activity and Therapeutic potential. Pharmacol Rep, 2011, 63, 849-858.
20. Hirata I, Naito Y, Takagi T, Mizushima K, Suzuki T, Omatsu T, Handa O et al.: Endogenous hydrogen sulfide is an anti-inflammatory molecule in dextran sodium sulfate-induced colitis in mice. Dig Dis Sci, 2011, 56, 1379-1386.
21. Hu LF, Wong PT, Moore PK, Bian JS: Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-Activated protein kinase in microglia. J Neurochem, 2007, 100, 1121-1128.
22. Kim HS, Kim HJ, Park KG, Kim YN, Kwon TK, Park JY: a-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kB transcriptional activity. Exp Mol Med, 2007, 39, 106-113.
23. Kimura H, Shibuya N, Kimura Y: Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid Redox Signal, 2012, 17, 45-57.
24. Kimura Y, Goto Y, Kimura H: Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal, 2010, 12, 1-13.
25. Lee M, Sparatore A, Del Soldato P, McGeer E, McGeer PL: Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia, 2010, 58, 103-113.
26. Lu C, Liu Y: Interactions of lipoic acid radical cations with vitamins C and E analogue and hydroxycinnamic acid derivatives. Arch Biochem Biophys, 2002, 406, 78-84.
27. Lowicka E, Beltowski J: Hydrogen sulfide (H2S) -The third gas of interest for pharmacologists. Pharmacol Rep, 2007, 59, 4-24.
28. McCarty MF, Barroso-Aranda J, Contreras F: The rejuvenatory impact of lipoic acid on mitochondrial function in aging rats may reflect induction and activation of PPAR-g coactivator-1a. Med HypoTheses, 2009, 72, 29-33.
29. Mikami Y, Shibuya N, Kimura Y, Nagahara N, Ogasawara Y, Kimura H: Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem J, 2011, 439, 479-485.
30. Nagahara N, Nishino T: Role of amino acid residues in The active site of rat liver mercaptopyruvate sulfurtransferase. cDNA cloning, overexpression, and site-directed mutagenesis. J Biol Chem, 1996, 271, 27395-27401.
31. Nagahara N, Okazaki T, Nishino T: Cytosolic mercaptopyruvate sulfurtransferase is evolutionarily related to mitochondrial rhodanese. Striking similarity in active site amino acid sequence and The increase in The mercaptopyruvate sulfurtransferase activity of rhodanese by site-directed mutagenesis. J Biol Chem, 1995, 270, 16230-16235.
32. Odabasoglu F, Halici Z, Aygun H, Halici M, Atalay F, Cakir A, Cadirci E et al.: a-Lipoic acid has antiinflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations. Br J Nutr, 2011, 105, 31-43.
33. Ogasawara Y, Isoda S, Tanabe S: Tissue and subcellular distribution of bound and acid-labile sulfur, and The enzymic capacity for sulfide production in The rat. Biol Pharm Bull, 1994, 17, 1535-1542.
34. Ohkita M, Takaoka M, Kobayashi Y, Itoh E, Uemachi H, Matsumura Y: Involvement of proteasome in endoThelin-1 production in cultured vascular endoThelial cells. Jpn J Pharmacol, 2002, 88, 197-205.
35. Packer L, Tritschler HJ, Wessel K: Neuroprotection by The metabolic antioxidant a-lipoic acid. Free Radic Biol Med, 1997, 22, 359-378.
36. Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW: Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One, 2010, 5, e13058.
37. Sen CK, Packer L: Antioxidant and redox regulation of gene transcription. FASEB J, 1996, 10, 709-720.
38. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM: Alpha-lipoic acid as a dietary supplement: molecular mechanisms and Therapeutic potential. Biochim Biophys Acta, 2009, 1790, 1149-1160.
39. Smith AR, Visioli F, Frei B, Hagen TM: Lipoic acid significantly restores, in rats, The age-related decline in vasomotion. Br J Pharmacol, 2008, 153, 1615-1622.
40. Suzuki YJ, Shi SS, Day RM, Blumberg JB: Differential regulation of MAP kinase signaling by pro-And antioxidant biothiols. Ann NY Acad Sci, 2000, 899, 159-167.
41. Szabo C: Hydrogen sulphide and its Therapeutic potential. Nat Rev Drug Discov, 2007, 6, 917-935.
42. Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y: Effects of a-lipoic acid on deoxycorticosterone acetate -salt-induced hypertension in rats. Eur J Pharmacol, 2001, 424, 121-129.
43. Toohey JI: Sulfur signaling: is The agent sulfide or sulfane? Anal Biochem, 2011, 43, 1-7.
44. Toohey JI: Sulphane sulphur in biological systems: a possible regulatory role. Biochem J, 1989, 264, 625-632.
45. Ubuka T, Abe T, Kajikawa R, Morino K: Determination of hydrogen sulfide and acid-labile sulfur in animal tissues by gas chromatography and ion chromatography. J Chromatogr B Biomed Sci Appl, 2001, 757, 31-37.
46. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V: Dietary a-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens, 2000, 18, 567-573.
47. Villarejo M, Westley J: Mechanism of rhodanese catalysis of thiosulfate-lipoate oxidation-reduction. J Biol Chem, 1963, 238, 4016-4020.
48. Wang R: Two's company, three's a crowd: can H2S be The third endogenous gaseous transmitter? FASEB J, 2002, 16, 1792-1798.
49. Winter CA, Risley EA, Nuss GW: Carrageenin-induced edema in hind paw of The rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med, 1962, 111, 544-547.
50. Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T et al.: Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science, 2001, 292, 1543-1546.
51. Yang G, Cao K, Wu L, Wang R: Cystathionine g-lyase overexpression inhibits cell proliferation via a H2S dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK. J Biol Chem, 2004, 279, 49199-49205.
52. Yazawa K, Suga K, Homma A, Shirosaki M, Koyama T: Anti-inflammatory effects of seeds of The tropical fruit Camu-Camu (Myrciaria dubia). J Nutr Sci Vitaminol, 2011, 57, 104-107.
53. Zanardo RCO, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J, 2006, 20, E1411-E1418.
54. Zhang WJ, Frei B: a-Lipoic acid inhibits TNF-A induced NF-kB activation and adhesion molecule expression in human aortic endoThelial cells. FASEB J, 2001, 15, 2423-2432.
55. . Zuidema MY, Peyton KJ, Fay WP, Durante W, Korthuis RJ: Antecedent hydrogen sulfide elicits an antiinflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1. Am J Physiol Heart Circ Physiol, 2011, 301, H888-H894